Non Hodgkin Lymphoma Incidence and Mortality by Year, New York City, 1976-2020

Source: New York State Cancer Registry

Year of Diagnosis/Death Incidence Mortality
Males and Females Males Females Males and Females Males Females
Cases Rate per 100,000 Population 95% CI Cases Rate per 100,000 Males 95% CI Cases Rate per 100,000 Females 95% CI Deaths Rate per 100,000 Population 95% CI Deaths Rate per 100,000 Males 95% CI Deaths Rate per 100,000 Females 95% CI
1976 818 11.0 10.3-11.8 407 13.4 12.1-14.8 411 9.5 8.6-10.5 453 6.2 5.6-6.8 249 8.5 7.5-9.7 204 4.7 4.1-5.4
1977 783 10.6 9.9-11.4 386 12.4 11.1-13.7 397 9.3 8.4-10.3 401 5.5 5.0-6.1 189 6.3 5.4-7.3 212 4.9 4.3-5.7
1978 813 11.2 10.4-12.0 415 13.4 12.1-14.8 398 9.5 8.6-10.5 427 5.8 5.3-6.4 233 7.7 6.7-8.9 194 4.5 3.9-5.2
1979 842 11.8 11.0-12.6 400 13.8 12.4-15.3 442 10.3 9.4-11.3 417 6.0 5.4-6.6 207 7.3 6.3-8.5 210 5.0 4.4-5.8
1980 941 13.1 12.2-14.0 461 15.3 13.9-16.8 480 11.3 10.3-12.4 436 6.0 5.4-6.6 228 7.5 6.5-8.6 208 4.9 4.2-5.6
1981 913 12.6 11.8-13.5 435 14.5 13.2-16.0 478 11.2 10.2-12.3 442 6.2 5.6-6.8 201 7.0 6.0-8.1 241 5.6 4.9-6.4
1982 1,020 14.2 13.3-15.1 470 15.6 14.2-17.1 550 12.9 11.8-14.0 463 6.5 5.9-7.2 217 7.6 6.6-8.8 246 5.7 5.0-6.5
1983 1,019 14.3 13.5-15.3 521 17.9 16.3-19.6 498 11.7 10.7-12.8 515 7.2 6.6-7.9 255 8.8 7.7-10.0 260 6.1 5.3-6.9
1984 1,051 14.5 13.7-15.5 530 17.9 16.4-19.6 521 12.1 11.0-13.2 451 6.3 5.7-6.9 233 8.0 7.0-9.2 218 5.0 4.3-5.7
1985 1,184 16.4 15.5-17.4 633 21.4 19.7-23.1 551 12.7 11.7-13.9 552 7.6 7.0-8.3 290 9.9 8.8-11.2 262 6.0 5.3-6.8
1986 1,253 17.2 16.2-18.2 661 21.5 19.9-23.3 592 13.7 12.6-14.8 501 7.0 6.4-7.6 274 9.4 8.3-10.6 227 5.2 4.5-5.9
1987 1,265 17.6 16.6-18.6 696 23.3 21.5-25.1 569 13.1 12.0-14.2 507 7.0 6.4-7.7 263 8.9 7.8-10.1 244 5.6 4.9-6.3
1988 1,172 16.2 15.3-17.2 645 21.1 19.5-22.9 527 12.4 11.3-13.5 567 7.9 7.3-8.6 295 10.2 9.0-11.5 272 6.2 5.4-6.9
1989 1,231 17.3 16.4-18.4 716 23.6 21.8-25.4 515 12.2 11.2-13.3 532 7.5 6.9-8.2 304 10.6 9.4-11.8 228 5.3 4.6-6.1
1990 1,395 19.4 18.3-20.4 811 26.4 24.5-28.3 584 13.7 12.6-14.9 544 7.6 7.0-8.3 273 9.4 8.3-10.6 271 6.3 5.5-7.1
1991 1,543 21.4 20.3-22.5 879 28.9 26.9-30.9 664 15.6 14.4-16.8 539 7.6 6.9-8.2 295 10.0 8.8-11.2 244 5.6 4.9-6.3
1992 1,497 20.7 19.7-21.8 832 26.8 25.0-28.8 665 15.8 14.6-17.1 562 7.9 7.2-8.5 288 10.1 8.9-11.4 274 6.3 5.6-7.2
1993 1,472 20.3 19.2-21.4 867 27.7 25.8-29.6 605 14.3 13.2-15.5 536 7.4 6.8-8.1 285 9.8 8.7-11.0 251 5.8 5.1-6.6
1994 1,724 23.7 22.6-24.9 1,000 31.5 29.5-33.6 724 17.2 16.0-18.5 571 8.0 7.3-8.7 288 9.9 8.7-11.1 283 6.5 5.8-7.4
1995 1,591 21.8 20.7-22.9 914 29.0 27.1-31.0 677 15.9 14.7-17.1 533 7.4 6.8-8.1 279 9.6 8.5-10.8 254 5.9 5.2-6.6
1996 1,589 21.6 20.6-22.7 881 28.2 26.3-30.1 708 16.6 15.4-17.9 554 7.7 7.1-8.4 285 10.1 8.9-11.3 269 6.2 5.5-7.0
1997 1,554 21.1 20.1-22.2 829 26.5 24.7-28.5 725 16.9 15.6-18.1 558 7.7 7.0-8.3 286 9.8 8.7-11.0 272 6.2 5.5-7.0
1998 1,470 19.7 18.7-20.7 799 25.0 23.2-26.8 671 15.6 14.5-16.9 562 7.7 7.1-8.3 268 8.9 7.9-10.1 294 6.7 5.9-7.5
1999 1,505 19.8 18.9-20.9 774 24.1 22.4-25.8 731 16.7 15.5-18.0 537 7.2 6.6-7.8 274 9.2 8.1-10.4 263 5.9 5.2-6.7
2000 1,465 19.1 18.1-20.1 751 22.8 21.2-24.5 714 16.1 14.9-17.3 512 6.7 6.2-7.3 258 8.5 7.5-9.6 254 5.6 4.9-6.3
2001 1,473 19.0 18.0-20.0 795 24.3 22.6-26.1 678 15.1 14.0-16.3 517 6.7 6.1-7.3 286 9.3 8.2-10.4 231 4.9 4.3-5.6
2002 1,460 18.6 17.7-19.6 804 23.9 22.3-25.7 656 14.5 13.4-15.7 469 6.0 5.5-6.6 256 8.1 7.1-9.2 213 4.6 4.0-5.2
2003 1,599 20.2 19.2-21.2 806 23.9 22.3-25.7 793 17.4 16.2-18.7 481 6.1 5.6-6.7 245 7.6 6.6-8.6 236 5.0 4.4-5.7
2004 1,537 19.4 18.5-20.4 798 23.7 22.1-25.5 739 16.2 15.1-17.4 464 5.9 5.4-6.5 239 7.6 6.6-8.6 225 4.8 4.2-5.4
2005 1,647 20.7 19.7-21.7 822 24.1 22.4-25.8 825 18.1 16.9-19.4 465 5.9 5.3-6.4 237 7.4 6.5-8.4 228 4.8 4.2-5.5
2006 1,595 19.9 19.0-20.9 869 25.3 23.6-27.1 726 15.8 14.7-17.0 467 5.9 5.4-6.5 238 7.4 6.5-8.4 229 4.9 4.3-5.6
2007 1,593 19.8 18.8-20.8 839 24.3 22.6-26.0 754 16.4 15.2-17.6 468 5.9 5.3-6.4 240 7.4 6.4-8.4 228 4.9 4.2-5.5
2008 1,674 20.5 19.5-21.5 900 25.7 24.0-27.4 774 16.6 15.4-17.8 420 5.2 4.7-5.7 228 6.9 6.0-7.9 192 4.0 3.4-4.6
2009 1,771 21.6 20.6-22.6 887 25.3 23.6-27.1 884 18.7 17.5-20.0 432 5.2 4.7-5.7 230 6.7 5.9-7.7 202 4.1 3.6-4.8
2010 1,672 20.0 19.1-21.0 882 24.6 22.9-26.3 790 16.5 15.4-17.7 409 5.0 4.5-5.5 211 6.3 5.5-7.3 198 4.0 3.5-4.6
2011 1,774 20.8 19.8-21.8 915 24.8 23.2-26.5 859 17.6 16.4-18.9 429 5.1 4.6-5.6 225 6.5 5.7-7.4 204 4.1 3.5-4.7
2012 1,744 20.1 19.2-21.1 938 25.1 23.5-26.8 806 16.5 15.4-17.7 433 5.0 4.5-5.5 235 6.7 5.8-7.6 198 3.8 3.3-4.4
2013 1,820 20.6 19.7-21.6 971 25.5 23.9-27.2 849 16.8 15.7-18.0 436 5.0 4.5-5.5 234 6.5 5.7-7.4 202 3.9 3.3-4.5
2014 1,813 20.1 19.2-21.1 965 25.0 23.4-26.6 848 16.5 15.4-17.7 426 4.7 4.3-5.2 227 6.1 5.3-7.0 199 3.7 3.2-4.3
2015 1,801 19.7 18.8-20.7 965 24.3 22.7-25.9 836 16.2 15.1-17.4 389 4.3 3.9-4.8 220 6.0 5.2-6.8 169 3.2 2.8-3.8
2016 1,863 20.0 19.1-20.9 985 24.2 22.7-25.8 878 16.8 15.6-17.9 442 4.7 4.3-5.2 237 6.1 5.3-6.9 205 3.7 3.2-4.3
2017 1,907 20.4 19.5-21.4 990 24.3 22.7-25.9 917 17.5 16.4-18.8 429 4.5 4.1-4.9 226 5.8 5.0-6.6 203 3.6 3.1-4.1
2018 1,882 20.0 19.1-21.0 990 24.2 22.6-25.7 892 16.8 15.7-18.0 384 3.9 3.5-4.3 218 5.4 4.7-6.2 166 2.8 2.4-3.3
2019 1,940 20.1 19.2-21.1 1,039 24.6 23.1-26.2 901 16.7 15.6-17.9 415 4.2 3.8-4.6 243 5.9 5.2-6.7 172 2.9 2.5-3.4
2020 1,629 16.9 16.1-17.8 847 20.0 18.7-21.4 782 14.5 13.4-15.5 359 3.6 3.2-4.0 209 5.0 4.4-5.8 150 2.5 2.1-3.0

Notes

  • Incidence data are provisional, November 2022.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 20 cases or deaths per year are unstable and should be used with caution.
  • Cancer diagnoses trends in 2020 may have been affected by the coronavirus disease 19 (COVID-19) pandemic.
  • The data in this table are not identical to the data in the corresponding 2016-2020 incidence table. See the rationale in 'Considerations When Comparing Cancer Statistics Over Time'.